Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.

ABSTRACT:

Trial registration

Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis (ROC), registered 22 October 2009, NCT01000441.

SUBMITTER: Riviere E 

PROVIDER: S-EPMC5994091 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature